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Abstract Kidney proximal tubulesare resistanto
hypoxicinjuryifglycineor L-alanineispresentintheir
incubationmedium. Protectiondoes not depend on the
concentration or turnover of ATP in cells. We have in-
vestigated structure-function relationships that govern
this protective activity. Among more than 45 amino
acidsand analogs examined, only glycine,L-alanine,
D-alanine,/3-alanine,and theneuronalglycinebinding
site agonist, 1-aminocyclopropane-1-carboxylic acid,
were active.The protectiveeffectcould not be ex-
plained by amino acid metabolism. Ultrastructural
features in protected cells were preserved to a degree
which suggestedthatprocessesresponsiblefordegra-
dation during hypoxia were retarded. These results are
consistentwith stringentrequirementsof amino acid
molecularstructureforprotectionagainsthypoxia,and
suggestthe involvement of highly specific,acceptor-
ligandeffectson a processcriticalformaintainingcel-
lular integrity. -WEINBERG, J. M.; VENKATACHALAM,
M. A.; GARZA-QUINTERO, R.; ROESER, N. F.; DAVIS,
J. A. Structuralrequirementsforprotectionby small
amino acids against hypoxic injury in kidney proximal
tubules.FASEBJ 4: 3347-3354; 1990.
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MAMMALIAN CELLS THAT ARE STRICTLY aerobic, such as
neurons and proximal tubule cells,are particularlysus-
ceptible to damage during hypoxia. High rates of oxi-
dative metabolism are coupled to membrane-based
transport functions in both celltypes.These properties
predispose them to rapid declines of adenosine tn-
phosphate (ATP) during periods of respiratory arrest.
Known strategiesthat protectcellsfrom hypoxic injury
involve energy turnover. For example, ectothermic
animals survive hypoxia by down-regulating the rates
of membrane transport and glycolysisin a coupled
fashion, i.e., by metabolic arrest (1). Pharmacologic in-
terventions that reduce work loads can protect certain
mammalian cells from hypoxic injury (2-4). In con-
trast, we and others have reported that glycine and
L-alanine, two small, neutral amino acids, confer upon
kidney tubule cellsstrikingtolerance to hypoxia and
other forms of injury that isunrelated to improvement
of cellularenergetics (5-11).We now report stringent
structuralrequirements for protection by the amino
acid molecules not related to their metabolic intercon-
versions.Also, we document the remarkable degree of
ultrastructuralpreservation seen in protected cells.
These observations suggest that hypoxia tolerance in-
duced by amino acids is mediated by ligand-acceptor
interactions with degradative processes responsible for
lethal injury.
METHODS
Isolation and incubation of tubules
Proximal tubules were isolatedfrom the kidney cortex
of New Zealand white rabbits ( 2.5 kg; Shankin’s
Rabbitry, Warren, Mich.) by collagenase digestion and
isopycnic centrifugation on Percoll gradients (5, 6).
Final tubule pellets were resuspended in ice-cold
medium gassed with 95% 02/5% CO2. The medium
contained 105 mM NaCl, 2.6 mM KC1, 25 mM
NaHCO3, 2.4 mM KH2PO4, 1.2 mM CaC12, 1.2 mM
MgCl2, 1.2 mM MgSO4, 0.6% dialyzed dextran (T40,
Pharmacia, Piscataway, N. J.). The medium also con-
tained 5 mM glucose, 4 mM sodium lactate, 1 mM L-
‘A preliminary report of some of the data in this paper was in-
cluded in the Minisymposium Molecular Targets of Cell Injury
presented at the 74th Annual Meeting of the Federation of Ameri-
can Societies for Experimental Biology, April 2, 1990, Washington,
D.C. Chaired by J. L. Farber and L. M. Buja.
2To whom correspondence and requests for reprints should be ad-
dressed, at: Nephrology Division, Rm. 1560, MSRB II, University
of Michigan Medical Center, Ann Arbor, MI 48109-0676, USA.
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alanine, and 10 mM sodium butyrate, a substrate com-
bination providing excellent stability of the tubule
preparation during in vitro study. Aliquots (5 ml) con-
taining 5-7.5 mg tubule protein/ml were placed in
siliconized25-ml flasks that were gassed with 95%
02/5% CO2, sealed, and kept on ice until use. Flasks
were gently shaken at 37#{176}Cin a water bath for warm
incubation. Tubules were initially incubated at 37#{176}C
for 15 mm. Then experimental additions were made
and flaskswere regassed with 95% N2/5% CO2 to
produce hypoxia or 95% 02/5% CO2 to maintain oxy-
genated conditions. Flasks were then sealed and re-
turned to the shaker. After 30 mm of hypoxic incuba-
tion, tubules were sampled for analysis without a
period of reoxygenation.
Analytical methods
IntracellularK” was measured by atomic absorption
spectroScopy in tubules separated from their medium
by centnifugation through bromododecane (Aldrich,
Milwaukee, Wis.) (5).ATP was determined by HPLC3
on trichloroacetic acid extracts (5). Lactate dehy-
drogenase (LDH) was measured in the medium before
and after addition of 0.1% Triton X-100, as described
(6). D-Alanine, L-alanine, and glutamate were assayed
enzymatically (12, 13). Protein was measured by the
Lowry method (14).
Morphology
Tubules were fixed in suspension or after pelletingat
12,000 g. Fixativeswere 2% glutaraldehyde in 0.1 M
sodium cacodylate buffer, pH 7.4 or 50 mM lysine-2%
glutaraldehyde (15). Postfixation and tissue processing
followed standard procedures.
Reagents
All reagents were obtained from Sigma (St. Louis,
Mo.) unless otherwise indicated. They were added
from 200-fold concentrated, neutral pH, aqueous stock
solutions.Unless otherwise indicated, L-amino acids
were used.
Statistics
Multiple groups were compared by analysisof variance
for repeated measure designs and the Neuman-Keuls
testfor multiple comparisons (PC ANOVA, Human
Systems Designs, Northnidge, Calif.). Differences with
P < 0.05 were considered statisticallysignificant.
RESULTS
Protection by glycine, alanine, and
1-aminocyclopropane-1-carboxylic acid
(ACPC)
Tubules supplemented with either 2 or 5 mM glycine,
L-alanine, /3-alanine, or D-alanine during 30 mm
hypoxia released less LDH than untreated tubules
(Fig. 1). At 2 mM, glycine reduced LDH release to a
greater extent than the other compounds. At 5 mM, L-
alanine reduced LDH release to the same degree as
glycine, and significantly more than f3-alanine and D-
alanine. -Alanine was more effectivethan D-alanine.
Among other compounds tested, another agent with
protective effects was identified. ACPC, an agonist at
the glycine modulatory site of the neuronal N-methyl-
D-aspartate (NMDA) receptor (16, 17), had a dose-
dependent effect similar to that seen with /3-alanine
(Fig. 1, insert).
Hypoxic tubules had sharp decreases of ATP and K
relative to controls (Table 1). Neither ATP nor K
levels were significantly affected by any of the treat-
ments. We had shown previously that altered metabolic
parameters (ATP, K) in hypoxic tubules treated with
glycine on L-alanine revert to normal values after
recovery in oxygenated medium, and that protection by
the amino acids lasts for hypoxic periods of as long as
90 mm (5, 7).Similar observations were made during
the present study (data not shown).
Morphology
Unsupplemented hypoxic tubules with 70-80% LDH
released to the medium were almost completely necrotic
(Fig. 2). In contrast, hypoxic tubules with protective
amino acids showed a degree of structural preservation
that could not be distinguished readily from oxy-
genated controls by light microscopy (Fig. 2). Hypoxic
tubules treated with D-alanine showed slightly greater
numbers of damaged cells than those treated with gly-
cine, L-alanine, f3-alanine, or ACPC. By electron
microscopy, most unsupplemented hypoxic tubules
showed total disruption of cell structure (Fig. 3A); a
small minority showed severe damage not amounting
to the necrosis shown in Fig. 3A. Figures 3B-D show
the morphology of glycine-protected tubules. In Fig.
3B, structural preservation is apparent in every tubule
profile as evaluated by light microscopy. The extent of
protection may be judged from the overall appearance
by electron microscopy and the preserved structure of
microvilli, cell junctional complexes, clathrin-coated
membrane pits, mitochondria, and peroxisomes (Fig.
3C, Fig. 3D). Focal areas of membrane fusion, swelling,
and blebbing of microvilli, and dissociation of actin
cores in microvilli attributable to ATP depletion were
indeed occurring in this population of cells. However,
the damage was minor, which indicates that progressive
structural disruption had been retarded (Fig. 3D). A
small minority of cells ( 10%) was necrotic, as might
be expected from the LDH data, and a similarly small
minority had intermediate forms of reversible damage
(not shown).
‘Abbreviations: LDH, lactate dehydrogenase; ACPC, 1-amino-
cyclopropane-1-carboxylic acid; HPLC, high-performance liquid
chromatography; NMDA, N-methyl-D-aspartate.
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Figure 1. Release of LDH during hypoxia. Free LDH is shown as the percentage of total LDH (medium + cells). Tubules were incubated
under oxygenated conditions for 15 mm and then for 30 mm with 02/002 (CONT), N2/C02 without supplements (HYPOX), or N,/C0,
with glycine (GLY), L-alanine (L-ALA), -alanine ($-ALA), or D-alanine (D-ALA). The agents were added at either 2 (open bars) or 5
mM (filled bars) at the start of hypoxia. There were separate oxygenated and hypoxic controls for the 2 and 5 mM groups. Values are
means ± SE (n - 4). Differences between tubules with amino acids and those without were significant (P < 0.01; P < 0.05 for 2 mM
D-ALA). At 2 mM, glycine was superior to all alanines (P < 0.05). At 5 mM, glycine and L-alanine were equally effective, and better
than fl-alanine and D-alanine (P < 0.05); j3-alanine was superior to D-alanine (P < 0.05). Inset) Similar data for 1-aminocyclopropane-1-
carboxylic acid (ACPC). 2 mM (open bars), 5 mM (filled bars). Oxygenated and hypoxic controls are shown as hatched bars. Values are
means ± SE (n 5-7). Differences among all groups, P < 0.01.
Relationship of protection to alanine metabolism
Since the standard incubation medium for all studies
contained 1 mM alanine, we studied the possible con-
tribution of alanine metabolism to the protective effects
by measuring the amino acid in the medium. Oxygenated
tubules consumed L-alanine rapidly; this metabolism
was suppressed during hypoxia (Fig. 4). Glutamate ap-
peared stoichiometrically as alanine disappeared (Fig. 4).
Consumption of L-alanine ceased during hypoxia re-
gardless of whether glycine, f3-alanine, or D-alanine had
been provided. This led to 500 eM L-alanine remain-
ing in the medium during the 30-mm hypoxic period
(Fig. 4, Fig. 5). L-Alanine levels of tubules treated with
additional L-alanine reflected the concentrations added
TABLE 1. Cell A TP and K during hypoxia with and
without amino acids
ATP K
nmol/mg c eli protein
Control
Hypoxia,
Hypoxia,
Hypoxia,
Hypoxia,
Hypoxia-
untreated
glycine
L-alanine
fl-alanine
D-alanine
11.14 ±
0.44 ±
1.12 ±
1.00 ±
1.13 ±
0.76 ±
1.18
0.06
0.22
0.12
0.18
0.15
346.5 ± 5.0
69.8 ± 2.5
67.1 ± 4.9
68.4 ± 3.9
72.3 ± 4.9
70.9 ± 5.6
Va1ues are means ± SE (n = 4). Control tubules were kept
oxygenated throughout. All other groups were subjected to 30-mm hypoxia
in the presence of 2 mM concentrations of the indicated amino acids.
(2 or 5 mM) plus the alanine remaining from that
originallyprovided in the incubation medium (Fig. 5).
D-Alanine concentrations at the end of hypoxia in tub-
ules treated with 2 and 5 mM concentrations were
2.1 ± 0.3 and 5.2 ± 0.5 mM, respectively.
Concentration dependence of protection
The effects of glycine and alanine were also compared
under conditions where alanine that was carried over
from the preincubation period was removed by washing
before hypoxia (Fig. 6). Glycine and alanine were simi-
larly and virtually completely protective at 5 mM, but
glycine was better at all lower concentrations (P < 0.01).
Effects of additional amino acids and
related compounds
A large number of additional compounds structurally
related to glycine and alanine were studied: other
amino acids, agents with activity at neuronal glycine
receptors, and metabolites and derivatives of glycine.
Table 2 shows the results and includes some related ob-
servations published earlier. None of these compounds
provided protection.
DISCUSSION
Among the more than 45 amino acids and analogs exa-
mined, only glycine, L-alanine, D-alanine, 3-alanine,
Figure 2. Low magnification photomicrographs of tubules fixed in suspension, pelleted, and processed for microscopy. Unsupplemented
hypoxic tubules (b) show virtually complete necrosis with few survivors compared with oxygenated controls (a). Tubules supplemented
with L-alanine (c), l-aminocyciopropane-1-carboxylic acid (d), and 13-alanine (e) show preservation of structure nearly as well as the con-
trols. Tubules with D-alanine (/) show good preservation of structure, but not as well as that seen with the other agents (x 130). All amino
acids were 5 mM.
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and ACPC were protective. Figure 7 summarizes
their structures and those of other closely related com-
pounds that were inactive. Glycine and L-alanine were
highly protective, as suggested by previous reports (5,
7, 8). Glycine was betterthan L-alanineat 2 mM, but not
at 5 mM. Alanine differsfrom glycine only in the
presence of a methyl group and in its chirality.
L-Alanine was more effectivethan D-alanine. Inserting
a methylene group in alanine to form a-aminobutynic
acid eliminated protection. Addition of an x-methyl
group to alanine to yield cx-aminoisobutyric acid also
made it inactive. However, the structurally similar cy-
clic compound, ACPC, had considerable activity. The
presence of hydroxylmethyl (senine) or mercaptomethyl
(cysteine)groups abolished activity. Transferring the
amino group of alanine to carbon 2 to form 13-alanine
did not substantially impair protection, but adding a
methyl group to /3-alanine to form /3-aminobutynic acid
negated the effect.
Both amino and carboxyl groups in their free form
are required to provide biological action. Thus taunine,
cysteamine (not shown in the figure), sarcosine, propar-
gylamine, betaine, aminoacetonitnile, ethanolamine
and alaninol, all of which have variations in structure
relative to glycine and alanine that are limited to either
their amino or carboxyl groups, showed no activity.
Propionic and aceticacid,which lackthe amino groups,
and methylamine, ethylamine, and isopropylamine
(not shown in the figure),which lack the carboxyl
groups, were also ineffective.Structurally unrelated
amino acids such as glutamate, glutamine, methionine,
phenylalanine, isoleucine, valine, aspartic acid, and
arginine were without effect.
These data indicate that a highly specific, limited
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Figure 3. A) Electron micrograph representative of the majority of hypoxic tubules without supplements, corresponding to the light micro-
graph (Fig. 2b). There is total disruption of cell structure (x 4000). B) Low magnification micrograph of hypoxic tubules given 2 mM gly-
cine, fixed after centrifugation and pelleting. Many tubules are compacted together, and most have a recognizable structure (x 130). C)
Electron micrograph corresponding to the majority of tubules seen in Fig. 3B. There is excellent overall preservation of cell structure except
for focal swelling of microvilli (x 4000). D) Electron micrograph (x 26,000) of cell from hypoxic tubules given 2 mM glycine. There is ex-
cellent preservation of cell ultrastructure including intact clathrin-coated membrane pit (small arrowheads), intercellular junctional com-
plexes (short arrow), mitochondria (m), peroxisomes (5), and lysosomes (Ly). There are focal areas of membrane damage and blebbing
in microvilli (wide arrows). Micrographs of higher resolution showed many areas of disruption of actin fibrils in the microvilli (not shown).
configuration is responsible for activity and that meta-
bolic transformation of the protective agents is proba-
bly not required. This conclusion is based on the mea-
surements of alanine in the present manuscript and
previously reported glycine determinations (5). L-
Alanine is metabolized by oxygenated tubules. The
simultaneous and stoichiometric production of gluta-
mate (Fig. 4) indicates that this metabolism involves
transamination. However, L-alanine metabolism was
completely inhibited during hypoxia. Moreover, both
glycine and L-alanine were fully protective even if they
were added only during hypoxia (refs 5, 7 and the
present study). There was also no measurable con-
sumption of L-alanine or D-alanine supplements.
D-Alanine is metabolized by D-amino acid oxidase (12):
this pathway is inoperative in the absence of oxygen.
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Figure 5. L-Alanine in the medium in the experiments described in
Fig. 1. Measurement was made at the end of 15 mm preincuba-
tion + 30 mm hypoxia. Bars marked cold show alanine levels at the
beginning of incubation when tubules were still in cold medium.
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Figure 4. Tubule suspension L-alanine and glutamate levels. Tub-
ules were incubated in the standard medium (1 mM alanine) either
continuously under oxygenated conditions or under hypoxic condi-
tions started after an initial 15 mm of oxygenated incubation. Con-
sumption of alanine is continuous during oxygenated conditions
and ceases during hypoxia. Alanine is 500 sM after 15 mm of
oxygenated incubation. Glutamate increases stoichiometrically as
alanine is consumed. Values are means ± SE (n 3).
There are no known metabolic interconversions of
ACPC.
Glycine in the kidney is mainly metabolized to serine
by a two step process beginning with the glycine
cleavage reaction (18, 19). Oxidative deamination by
glycine oxidase to glyoxylate may also occur (19).
Neither serine nor glyoxylate was protective. Thus,
even if glycine had been partially metabolized to serine
or glyoxylate, such a conversion cannot explain protec-
tion. Aminoacetonitrile, propargylamine, valproic acid,
and cysteamine, which all inhibit the glycine cleavage
system (20), neither protected against nor exacerbated
injury. Incorporation of glycine into proteins, purines,
and other complex molecules is an unlikely explana-
tion, as these energy-dependent reactions would cease
during hypoxia.
Glycine is actively transported and concentrated to
high levels in oxygenated, metabolizing proximal tub-
ule cells (21). However, our data show that the protec-
tive amino acids are effective even if they are present
only during hypoxia when active transport is not a fac-
CONCENTRATION OF AMINO ACID (mM)
Figure 6. Concentration dependence of protection mediated by gly-
cine and L-alanine. Tubules were incubated with 02/C02 for 15
mm. resuspended in fresh medium with either glycine or L-alanine
in different concentrations from 0.25 to 5 mM, and immediately
gassed with N2/CO, for 30 mm of hypoxia. Values are means ± SE
(n 4).
tor. Under these conditions, they rapidly reach intracel-
lular concentrations similar to medium levels (22).
The protective effects were not mediated by cell ATP.
Slightly higher ATP levels of glycine-protected cells in
previous studies were likely an effect rather than the
cause of structural preservation (6, 7, 9). Cell K, a sen-
sitive indicator of energy availability (6, 9), fell to simi-
lar levels in protected and unprotected cells. We have
also observed that the rates of decline of ATP mass and
of 32P (Pi)-labeled ATP are similar in protected and un-
protected tubules (data not shown).
Based on the apparent lack of a requirement for
metabolism for these protective effects, a comparison of
structure activity relationships reported here with those
defined for neuronal glycine receptors is relevant. Two
classes of glycine receptors have been characterized in
neuronal cells. The strychnine-sensitive, inhibitory gly-
cine receptor is half-maximally activated at glycine
levels of approximately 100 tM (23). L-Alanine, D-
alanine, L-serine, taurine, and f3-alanine are also
agonists for this receptor (23, 24). L-Serine and taurine
did not protect kidney tubules from hypoxia. Recently,
a high-affinityneuronal glycine binding site, with
effects to modulate activity of the N-methyl-D-aspartate
subtype of glutamate receptors, has been described (17,
25-27). ACPC and D-alanine, which protected renal
tubules from hypoxia, are agonists for the NMDA-
modulatory site (16, 17, 28). However, D-serine is also
a potent agonist at this site (28) and was ineffective in
the tubule system. Two antagonists at the glycine-
modulatory site, kynurenic acid (26, 29) and cycloleu-
cine (30), lacked effects on the tubules, and in other
studies (not shown) did not alter the effects of glycine.
Thus, the protective effects of glycine have overlap-
ping degrees of specificity to those evident at neuronal
glycine receptors. This comparison suggests that a
reversible ligand binding site interaction with highly
constrained steric, electronic, and conformational re-
quirements accounts for protection as it does for neu-
ronal binding. However, the interaction must be of
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TABLE 2. LDH release by hypoxic proximal tubules during treatment with
additional amino acids and related compound?
L-Glutamate
L-Glutamine
L-Cysteine
Taurine
L-Serine
D-Serine
L-Methionine
L-Phenylalanmne
L-Isoleucine
L-Valine
L-Arginine
L-Aspartate
a-Aminoisobutyric acid
L-cx-Aminobutyric acid
DL-f3-Aminobutyric acid
y-Aminobutyric acid
L-a-Aminovaleric acid
t5-Aminovaleric acid
Ethanolamine
Alaninol
Acetate
Propionate
Glyoxylate
Sarcosine
Propargylamine
Betaine
Acetonitrile
Glycyl-sarcosine
Glycine anhydride
Iminodiacetic acid
f3-Chloro-L-alanine
13-Chloro-D-alanine
N-acetyl-L-cysteine
Cysteamine
Valproic acid
Kynurenic acid
Cycloleucine
Percent free LDH
Not protective (ref 5)
Not protective (ref 7)
Not protective (ref 5)
77.0 ± 6.8
Not protective (ref 5)
76.4 ± 6.6
61.9 ± 5.8
67.3 ± 3.5
63.9 ± 3.4
66.6 ± 4.4
Not protective (ref 7)
Not protective (ref 7)
57.9 ± 4.0
71.1 ± 5.4
63.8 ± 3.4
60.1 ± 4.3
69.1 ± 5.6
67.2 ± 3.3
Values are means ± SE of data from at least four experiments except
for the acetate, propionate, glycine anhydride, and glycylsarcosine groups,
which consisted of experiments on three tubule preparations. The
experimental agents were studied in seven groups, each of which also
included paired time control, untreated hypoxic, and glycine-treated
hypoxic tubules. Average percent free LDH values from the seven
experimental groups were: time control, 13.4; hypoxia, 66.1; hypoxia + 2
mM glycine, 19.7. Test agents in all groups were added at 2 mM coincident
with the start of hypoxia. In at least two additional studies, the following
compounds were also tested at 5 mM: glutamate, L-sersne, L-cysteine, a-
aminoisobutyric acid, L-a-aminobutyrlc acid, DL-fl-aminobutyrlc acid, ‘y-
aminobutyric acid, valine, and isoleucine. Several additional compounds
not listed above were also tested in two studies: L-leucine (5 mM), L-
threonine (5 mM), pyruvate (5 mM), methylamine (2 and 5 mM),
ethylamine (2 and 5 mM), and isopropylamine (2 and 5 mM). None of
these compounds provided protection relative to the paired, untreated
hypoxic preparations.
lower affinity and does not correspond to either of the
known receptor types.
Glycine and alanine are used as osmolytes in tissues
of various organisms. They are nonperturbing for pro-
tein structure and function over a broad range of con-
centrations (31). Methylamines such as betaine and sar-
cosine, which serve as osmolytes in urea-rich tissues,
including the renal medulla (32), counteract destabiliz-
ing influences of urea on protein structure (31). When
they are present in concentrations of 0.5-1 M, glycine,
alanine, 3-alanine, betaine, L-serine, -y-aminobutyric
acid, sarcosine, and taurine stabilize protein structure
against thermal denaturation without changing hydra-
tion values. This indicates that they are excluded from
the protein domain and are unlikely to be directly
bound (33). These low-affinity protein interactions with
diverse osmolytes are unlikely to explain the effectsof
glycine, alanine, and ACPC on proximal tubules. The
latter are more likely mediated by specific ligand bind-
ing such as those of glycine with neuronal receptors.
Ischemia-reperfusion injury is now widely considered
to result from both oxygen deprivation and reoxygena-
tion components. Hypoxic injury to this tubule prepa-
ration results primarily from oxygen deprivation, as 1)
injury is very similar during severe hypoxia and com-
plete anoxia (34), 2) deliberate reoxygenation after
hypoxia or anoxia does not produce further injury (5,
34, 35), and 3) a variety of antioxidant treatments do
not modify the development of injury (5). Thus, scav-
enging of reactive oxygen species by the amino acids is
unlikely to be critical for protection. We have also con-
sidered whether formation of acyl-amino acid conju-
gates could contribute to protection by detoxifying free
fatty acids released during hypoxic injury, but so far we
have not been able to document this mechanism of ac-
tion (35).
Important morphological features of protected tub-
ules were the preservation of the internal structure of
cell organelles, and cohesion of the organelles and
cytoplasm to such a degree as to simulate superfically
the normal state. Close inspection revealed that
changes attributable to ATP depletion such as disas-
sembly of actin fibrils and swelling of the microvilli
were occurring in variable degrees. Nevertheless, we
were struckby the overallstructuralintegrity,and infer
that degradative processes responsible for the disin-
tegration of cells had been retarded. Whereas the deg-
radative events must involve multiple targets, and are
probably interactive in nature, the effects of glycine
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analogs appear to be determined by strictrequirements
of molecular mimicry. Therefore, protection should in-
volve acceptor-ligand interaction (or interactions) with
binding sites that must meet correspondingly stringent
requirements of structure. Also, such interactions must
be close enough in the sequence of degradation to ex-
plain the apparent preemption of the entire cascade of
injury. However, the nature of these putative molecular
interactions and mechanisms that underlie protection
remain to be completely defined.
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